1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Vildagliptin Enhances Islet Responsiveness to Both Hyper- and Hypoglycemia in Patients with Type 2 Diabetes.
(
- Contribution to journal › Article
- 2007
-
Mark
Improved metabolic risk markers following two 6-month physical activity programs among socioeconomic marginalized women of native American ancestry in Lima, Peru
(
- Contribution to journal › Article
-
Mark
The impact of large tidal volume ventilation on the absorption of inhaled insulin in rabbits.
(
- Contribution to journal › Article
-
Mark
Insulin secretion and insulin sensitivity in relation to fasting glucose in healthy subjects.
(
- Contribution to journal › Article
- 2006
-
Mark
Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after 2 years of GH treatment in GH deficient adult survivors of childhood acute lymphoblastic leukaemia.
(
- Contribution to journal › Article
-
Mark
Klinisk forskning måste baseras på team av både kliniker och forskare
(
- Contribution to journal › Letter
-
Mark
A Novel Approach to Assess Insulin Sensitivity Reveals No Increased Insulin Sensitivity in Mice with a Dominant-Negative Mutant Hepatocyte Nuclear Factor-1{alpha}
2006) In American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 291(1). p.131-137(
- Contribution to journal › Article
-
Mark
Vildagliptin: an inhibitor of dipeptidyl peptidase-4 with antidiabetic properties.
(
- Contribution to journal › Article
- 2005
-
Mark
Assessment of insulin secretion in relation to insulin resistance.
(
- Contribution to journal › Article
-
Mark
A 90-day toxicological evaluation of 1,5-anhydro-d-fructose in Sprague-Dawley rats.
(
- Contribution to journal › Article